Why the study?
How do antiplatelet drugs affect platelet impedance aggregation in whole blood from normal volunteers?
How do antiplatelet drugs affect platelet impedance aggregation in whole blood from normal volunteers?
The electrical impedance method is suitable for studying platelet aggregation in whole blood, demonstrating dose-dependent inhibition by various antiplatelet agents.
Answers are grounded in this paper and cite their sources.
May inform preclinical antiplatelet testing; leaves open human translation and clinical utility.
Platelet aggregation was studied in citrated whole blood by an electrical impedance method. Blood samples from normal volunteers were studied with the aim of finding a suitable method for the routine study of samples from patients. An erratic tracing and low maximum aggregation were seen in samples with a high normal haematocrit. Optimal aggregation was seen when blood was diluted to a haematocrit of .300; isotonic saline was a better diluent than platelet poor plasma. No appreciable differences were seen when the platelet count was diluted down to 50 X 10(9)/l, after which there was a progressive reduction in response. Dose response curves were obtained, and normal ranges for ADP, collagen, and sodium arachidonate were determined. Acetylsalicylic acid had a more pronounced effect on ADP aggregation than on collagen. Prostacyclin (Epoprostenol) and the synthetic prostacyclin analogue ZK 36,374 both showed dose dependent inhibition of aggregation, but the duration of effect of the latter was much longer (greater than 6 h).
No takes yet. Share an insight, caveat, or question.
Mackie et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: